Slider

1986
IBM’s Thomas J. Watson Research Center and researchers at the University of California, Davis, begin collaborative development of an innovative system for Total Hip Arthroplasty (THA). Their goal was to create a robotic surgical system that will redefine precision in joint replacement procedures.

1992
The ROBODOC® Surgical System makes medical history. By assisting a surgeon in a THA procedure, the system becomes the first of its kind to be used on humans. This breakthrough leads to rapid development of three-dimensional image-directed, preoperative planning and computer-guided robotic surgery. That same year the ROBODOC® development team receives the prestigious Computerworld Smithsonian Award for Innovation in the Arts and Sciences for Medicine.

1994
Commercialization of the ROBODOC® Surgical System begins in Europe while the Company continues to push the cutting edge of robotic technology forward in orthopedics. Among ROBODOC® advancements are Total Hip Arthroplasty with cementless implant, Total Knee Arthroplasty*, and Revision Total Hip Arthroplasty.

* TKA and RTHA not available for sale in U.S.

2007
A partnership with Curexo Inc. of Korea enables ROBODOC® to complete clinical studies at three major United States hospitals and proceed with the next level of technical development.

2008
The ROBODOC® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures. It is still the only active robotic system cleared by the U.S. FDA for orthopedic surgery.

2010
The first commercial system established at Sutter General Hospital in Sacramento, CA.

2014
Curexo Technology becomes THINK Surgical, Inc., committed to developing and commercializing advanced computer-assisted systems for leading-edge joint replacements.

2014
ROBODOC® EncoreTM Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures.

2014
August 2014: TSolution One® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty procedures.

2015
September 2015: TSolution One® Surgical System receives CE mark for Total Hip Arthroplasty procedures.

2015
October 2015: TSolution One® Surgical System receives 510(k) clearance from the United States Food and Drug Administration (FDA) for Total Hip Arthroplasty and Cup Placement procedures.

2016
November 2016: The 1989 ROBODOC® prototype, the TSolution One® core technology, was added to the Smithsonian National Museum of American History as part of their Science and Medicine Collection.

2017
December 2017: TSolution One® Surgical System receives CE mark for  Total Knee Arthroplasty.